Albeck A - Search Results

1

α-Aminoisobutyric Acid Leads a Fluorescent syn-bimane LASER Probe Across the Blood-brain Barrier.

Lapidot I, Baranes D, Pinhasov A, Gellerman G, Albeck A, Grynszpan F, Shatzmiller SE. Lapidot I, et al. Among authors: albeck a. Med Chem. 2016;12(1):48-53. doi: 10.2174/1573406411666150518105010. Med Chem. 2016. PMID: 25981518

2

"Switch off/switch on" regulation of drug cytotoxicity by conjugation to a cell targeting peptide.

Gilad Y, Firer MA, Rozovsky A, Ragozin E, Redko B, Albeck A, Gellerman G. Gilad Y, et al. Among authors: albeck a. Eur J Med Chem. 2014 Oct 6;85:139-46. doi: 10.1016/j.ejmech.2014.07.073. Epub 2014 Jul 22. Eur J Med Chem. 2014. PMID: 25084142

3

Biolabile peptidyl delivery systems toward sequential drug release.

Ragozin E, Redko B, Tuchinsky E, Rozovsky A, Albeck A, Grynszpan F, Gellerman G. Ragozin E, et al. Among authors: albeck a. Biopolymers. 2016 Jan;106(1):119-32. doi: 10.1002/bip.22794. Biopolymers. 2016. PMID: 26662352

4

Antimicrobial benzodiazepine-based short cationic peptidomimetics.

Zats GM, Kovaliov M, Albeck A, Shatzmiller S. Zats GM, et al. Among authors: albeck a. J Pept Sci. 2015 Jun;21(6):512-9. doi: 10.1002/psc.2771. Epub 2015 Mar 25. J Pept Sci. 2015. PMID: 25807936

5

Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery.

Gilad Y, Noy E, Senderowitz H, Albeck A, Firer MA, Gellerman G. Gilad Y, et al. Among authors: albeck a. Bioorg Med Chem. 2016 Jan 15;24(2):294-303. doi: 10.1016/j.bmc.2015.12.020. Epub 2015 Dec 12. Bioorg Med Chem. 2016. PMID: 26719208

6

Dual-drug RGD conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cells.

Gilad Y, Noy E, Senderowitz H, Albeck A, Firer MA, Gellerman G. Gilad Y, et al. Among authors: albeck a. Biopolymers. 2016 Mar;106(2):160-171. doi: 10.1002/bip.22800. Biopolymers. 2016. PMID: 26715008

7

Anti-neoplastic activity of 1,3-diaza-2-functionalized-adamantan-6-one compounds against melanoma cells.

Sharabi-Ronen Y, Levinger S, Lellouche MB, Albeck A. Sharabi-Ronen Y, et al. Among authors: albeck a. Med Chem. 2014;10(1):27-37. doi: 10.2174/15734064113099900002. Med Chem. 2014. PMID: 23627298

8

Peptidyl epoxides extended in the P' direction as cysteine protease inhibitors: effect on affinity and mechanism of inhibition.

Perlman N, Hazan M, Shokhen M, Albeck A. Perlman N, et al. Among authors: albeck a. Bioorg Med Chem. 2008 Oct 1;16(19):9032-9. doi: 10.1016/j.bmc.2008.08.031. Epub 2008 Aug 19. Bioorg Med Chem. 2008. PMID: 18789705

9

13-Demethyl-13-substituted-13,14-dihydroretinols as potential affinity labels of retinol-binding proteins: syntheses and stability studies.

Yefidoff R, Weiss L, Avisar D, Albeck A. Yefidoff R, et al. Among authors: albeck a. Bioorg Chem. 2004 Feb;32(1):38-50. doi: 10.1016/j.bioorg.2003.09.002. Bioorg Chem. 2004. PMID: 14700561

10

Beta-Carotene derivatives as novel therapy for the prevention and treatment of autistic symptoms.

Avraham Y, Mankuta D, Lipsker L, Vorobiev L, Patael S, Hassid G, Berry EM, Albeck A. Avraham Y, et al. Among authors: albeck a. Bioorg Chem. 2021 Oct;115:105224. doi: 10.1016/j.bioorg.2021.105224. Epub 2021 Aug 3. Bioorg Chem. 2021. PMID: 34392174

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters